Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

ENvue Medical Resumes U.S. Commercial Shipments of NanoVibronix PainShield® and Begins Fulfilling Open Distributor Orders

$FEEDPress releaseSep 9, 2026, 8:30 AM ETRead the release

ENvue Medical (NASDAQ: FEED) has resumed U.S. commercial shipments of PainShield, now manufactured in the United States, and begun fulfilling open orders from Ultra Pain Products, its exclusive U.S. distributor for the product. The resumption follows the transfer of NanoVibronix manufacturing operations from Israel to the U.S.; U.S.

AI analysis

Red flags3 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.